Rafael Azoubel

Mr. Rafael Azoubel

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
PRPaula de Freitas Rosa Remiro
Paula de Freitas Rosa Remiro
MNMariana Harue Taniguchi Nagahara
Mariana Harue Taniguchi Nagahara
RARafael Azoubel
Rafael Azoubel
Michelle Franz-MontanMichelle Franz-Montan
Michelle Franz-Montan
MDMarcos Akira D’Ávila
Marcos Akira D’Ávila
ÂMÂngela Maria Moraes
Ângela Maria Moraes
There are several routes of drug administration, and each one has advantages and limitations. In the case of the topical application in the oral cavity, comprising the buccal, sublingual, palatal, and gingival regions, the advantage is that it is painless, non-invasive, allows easy application of the formulation, and it is capable of avoiding the need of drug swallowing by the patient, a matter of relevance for children and the elderly. Another advantage is the high permeability of the oral mucosa, which may deliver very high amounts of medication rapidly to the bloodstream without significant damage to the stomach. This route also allows the local treatment of lesions that affect the oral cavity, as an alternative to systemic approaches involving injection-based methods and oral medications that require drug swallowing. Thus, this drug delivery route has been arousing great interest in the pharmaceutical industry. This review aims to condense information on the types of biomaterials and polymers used for this functionality, as well as on production methods and market perspectives of this topical drug delivery route.

6 November 2022 in Polymers
Verified
Journal Article
Open access
PDF file
FAFlavia Figueiredo Azevedo
Flavia Figueiredo Azevedo
TCThiago Anselmo Cantarutti
Thiago Anselmo Cantarutti
PRPaula de Freitas Rosa Remiro
Paula de Freitas Rosa Remiro
BBBeatriz Barbieri Bortolozo
Beatriz Barbieri Bortolozo
RARafael Azoubel
Rafael Azoubel
Maria Helena Melo LimaMaria Helena Melo Lima
Maria Helena Melo Lima
The purpose of this study was to investigate tissue repair of excisional wounds in hyperglycemic animals treated with chitosan-alginate membranes (CAM) produced in the presence of glycerol. 8-week C57B1 male mice were divided into normoglycemic animals with a 0.9% saline solution topical treatment (CTSF); hyperglycemic animals with 0.9% saline solution topical treatment (DMSF) and hyperglycemic animals with glycerol-plasticized chitosan-alginate membrane topical treatment (DMCAM). On post-wound day three, the DMCAM group presented a lower number of leukocytes, mature mastocytes, a higher number of vessels (p < 0.05), and active mastocytes (p < 0.05) when compared to the CTSF and DMSF groups. There were no differences regarding the distribution, deposition, organization, and thickness of collagen fibers. On day 7 there were no differences in the analysis of fibroblasts, mastocytes, and TGF−β1 and VEGF expressions among the groups. Regarding collagen fibers, the DMCAM group presented slight red-orange birefringence when compared to the CTSF and DMSF groups. On day 14 there was a slight concentration of thinner elastic fibers for the DMCAM group, with a greater reorganization of papillary skin and improved red-orange birefringence collagen fibers, as well as net-shaped orientation, similar to intact skin. In addition, improved elastic fiber organization distributed in the entire neo-dermis and a larger presence of elaunin fibers were observed, in a similar pattern found in the intact skin. The use of CAM in cutaneous lesions boosted tissue repair since there was a smaller number of inflammatory cells and mastocytes, and an improvement in collagen deposition and collagen fibers. These results demonstrate the high potential of plasticized chitosan-alginate membrane for skin wound dressing of hyperglycemic patients.